Trial intelligence / Profile preview

Hydrocortisone for improving pneumatic reduction outcomes in infantile intussusception

PACTR201602001480323Recruiting

Sponsor
Cairo University
Start
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of hydrocortisone in intussusception (2 arms), sponsored by Cairo University. Primary endpoint: Success of pneumatic reduction. Started Apr 2015; status: recruiting.

02

Drugs

hydrocortisone
03

Conditions

intussusception

Beyond the preview

Go deeper on PACTR201602001480323.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201602001480323.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call